Project Grant R21EY034993
Award Date
9/1/24
Completion Date
8/31/26
Dollars Obligated
$215K
Federal Agency
National Eye Institute
Awardee
Duke University (TP7EK8DZV6N5)
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Durham, NC 27708, USA
Similar Awards
The National Eye Institute (NEI) awarded a $193,168 Project Grant (CFDA 93.867 Vision Research) to Duke University to develop a novel, auto-aligning hand-held optical coherence tomography (OCT) and OCT angiography (OCTA) probe for routine and repeatable high-quality retinal imaging in infants and children. The research aims to address the challenges associated with obtaining consistent OCT and OCTA data capture in uncooperative pediatric patients. The expected outcomes include a set of...
This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) to New York University School of Medicine provides $673,747 to develop a visible-to-near-infrared spanning optical coherence tomography (OCT) system capable of imaging retinal structures at a resolution of up to 0.5 microns. The goal is to leverage this advanced OCT technology to study the spatiotemporal relationship of key biomarkers such as macular pigments and retinal pigment epithelium melanosomes, and...
The National Eye Institute (NEI) awarded a $256,296 Project Grant (CFDA 93.867 - Vision Research) to The General Hospital Corporation (Massachusetts General Hospital) to develop new "Auto-Sensing, Instantaneous Adaptive Ranging Optical Coherence Tomography (OCTA)" technology. This technology aims to expand the imaging depth range of OCTA systems, enabling improved visualization of the critical peripheral retinal microvasculature. The project will leverage advances in integrated...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), is providing $306,462 to Ifocus Imaging LLC to develop a software platform called OCT-ART-DR. The platform will automate the diagnosis and staging of diabetic retinopathy using optical coherence tomography angiography (OCTA) imaging and artificial intelligence. The key products to be delivered under this award include: 1) Improved AI-based segmentation of OCTA image...
This Project Grant award from the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867) will fund the development of a new wide-field visible-light optical coherence tomography (WF-VIS-OCT) device to evaluate the oxygen-induced retinopathy (OIR) model in rats. The $623,090 award, effective September 1, 2024, will support the Oregon Health & Science University in three main efforts: 1) developing the WF-VIS-OCT system with 5-mm transverse resolution over a...
The National Eye Institute (NEI), under the federal Vision Research program (CFDA 93.867), awarded a $300,001 Project Grant to Kineolabs, Inc. in Billerica, MA. The objective of this 1-year grant, which runs from July 1, 2025 to June 30, 2026, is to develop a portable, low-cost line-scan swept-source optical coherence tomography (LS-SS-OCT) imaging system. This system is intended for early detection and monitoring of age-related macular degeneration (AMD), diabetic retinopathy, and other eye...
This federal Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) provides $881,796 to Siloam Vision, Inc. to develop two advanced, laser-based, AI-enabled retinal imaging systems. The key innovations are: A wider field-of-view camera design that can be paired with either a scanning laser ophthalmoscope (SLO) or optical coherence tomography (OCT) system, offering 2D or 3D imaging, respectively. This aims to address an unmet need in retinopathy...
The National Eye Institute (NEI) awarded a $179,964 Project Grant under the Vision Research federal grant program (CFDA 93.867) to the University of California, Irvine (UCI) with a project period from March 1, 2025 to July 10, 2029. The project aims to develop innovative deep learning-based retinal optical coherence tomography (OCT) biomarkers to improve the diagnosis and management of optic neuropathies, a group of eye diseases that primarily target the optic nerve and frequently result in...
This $433,841 federal Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) supports the development of computational methods and deep learning models to analyze imaging data and identify biomarkers for age-related macular degeneration (AMD). The goal is to improve understanding of AMD disease progression and response to treatment. Specifically, the project will develop deep neural network models to analyze optical coherence tomography,...
This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) aims to develop a novel, non-invasive, and sensitive measure of retinal dysfunction. The $491,466 award, effective January 1, 2025 through December 31, 2026, will support research at the University of California, San Francisco to expand a methodology using the optokinetic reflex (OKR) to detect and monitor localized cone and inner retinal function in patients with retinitis pigmentosa and diabetic...